CN116407598A - 肺疫清纯中药 - Google Patents
肺疫清纯中药 Download PDFInfo
- Publication number
- CN116407598A CN116407598A CN202210004353.3A CN202210004353A CN116407598A CN 116407598 A CN116407598 A CN 116407598A CN 202210004353 A CN202210004353 A CN 202210004353A CN 116407598 A CN116407598 A CN 116407598A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- plague
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 33
- 206010035148 Plague Diseases 0.000 title claims abstract description 31
- 241000607479 Yersinia pestis Species 0.000 title claims abstract description 31
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 14
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 14
- 244000237330 gutta percha tree Species 0.000 claims abstract description 13
- 235000004347 Perilla Nutrition 0.000 claims abstract description 12
- 244000274050 Platycodon grandiflorum Species 0.000 claims abstract description 12
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 12
- 241000123887 Pulsatilla chinensis Species 0.000 claims abstract description 12
- 229940126680 traditional chinese medicines Drugs 0.000 claims abstract description 9
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 4
- 210000000582 semen Anatomy 0.000 claims abstract description 3
- 244000124853 Perilla frutescens Species 0.000 claims abstract 4
- 239000012141 concentrate Substances 0.000 claims description 23
- 239000007787 solid Substances 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 21
- 239000006187 pill Substances 0.000 claims description 18
- 239000002994 raw material Substances 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 244000068988 Glycine max Species 0.000 claims description 9
- 235000010469 Glycine max Nutrition 0.000 claims description 9
- 240000002505 Pogostemon cablin Species 0.000 claims description 9
- 235000011751 Pogostemon cablin Nutrition 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 238000005303 weighing Methods 0.000 claims description 9
- 241001233061 earthworms Species 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 235000014347 soups Nutrition 0.000 claims description 2
- 240000007171 Imperata cylindrica Species 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 210000004072 lung Anatomy 0.000 abstract description 9
- 230000008901 benefit Effects 0.000 abstract description 4
- 201000006306 Cor pulmonale Diseases 0.000 abstract description 2
- 206010014561 Emphysema Diseases 0.000 abstract description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract description 2
- 208000004186 Pulmonary Heart Disease Diseases 0.000 abstract description 2
- 240000007164 Salvia officinalis Species 0.000 abstract description 2
- 239000008280 blood Substances 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 abstract description 2
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 210000001124 body fluid Anatomy 0.000 abstract description 2
- 239000010839 body fluid Substances 0.000 abstract description 2
- 206010006451 bronchitis Diseases 0.000 abstract description 2
- 230000007812 deficiency Effects 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 201000005202 lung cancer Diseases 0.000 abstract description 2
- 208000020816 lung neoplasm Diseases 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 235000005412 red sage Nutrition 0.000 abstract description 2
- 210000000952 spleen Anatomy 0.000 abstract description 2
- 230000002685 pulmonary effect Effects 0.000 abstract 2
- 241000229722 Perilla <angiosperm> Species 0.000 description 8
- 241001598107 Imperata Species 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000007873 sieving Methods 0.000 description 5
- 241000282887 Suidae Species 0.000 description 4
- 230000008569 process Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010034107 Pasteurella infections Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 201000005115 pasteurellosis Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中药技术领域，且公开了肺疫清纯中药，包括以下重量份的成分：太子参15～25份、丹参10～30份、柴胡20～35份、白茅根20～45份、紫苏叶10～30份、桔梗10～20份、苍术15～20份、玄参20～30份、淡豆鼓20～30份、地龙20～30份，白头翁20～30份、杜仲20～30份、红花15～20份、广藿香5～15份。该肺疫清纯中药，能够快速对肺疫患者的情况进行改善，通过红花、丹参进行活血化瘀，并用杜仲、太子参进行滋补，补脾益肺，益气生津，加速患者的治愈速度，具有一定的保健功能，适用于肺气肿，肺大泡，中期肺癌，肺气虚，支气管炎，肺心病。
Description
技术领域
本发明涉及中药技术领域，具体为肺疫清纯中药。
背景技术
肺疫是由多种杀伤性巴氏杆菌所引起的一种急性传染病。急性或慢性经过，急性呈败血症变化，咽喉部肿胀，高度呼吸困难，现有的肺疫用药多为西药，用量大且有副作用，而中草药则毒副作用小，几乎无残留、无抗药性，对环境影响小，为此我们提出了一种肺疫清纯中药。
发明内容
（一）解决的技术问题
针对现有技术的不足，本发明提供了肺疫清纯中药，具备快速有效无副作用的治愈肺疫，且具有滋补功效等优点，解决了现在市面上的肺疫患者用药用量大副作用多的问题。
（二）技术方案
为实现具备快速有效无副作用的治愈肺疫，且滋补功效的目的，本发明提供如下技术方案：肺疫清纯中药，包括以下重量份的成分：太子参15～25份、丹参10～30份、柴胡20～35份、白茅根20～45份、紫苏叶10～30份、桔梗10～20份、苍术15～20份、玄参20～30份、淡豆鼓20～30份、地龙20～30份，白头翁20～30份、杜仲20～30份、红花15～20份、广藿香5～15份。
进一步的，包括以下重量份的成分：太子参15份、丹参20份、柴胡30份、白茅根40份、紫苏叶20份、桔梗15份、苍术20份、玄参25份、淡豆鼓25份、地龙20份，白头翁30份、杜仲30份、红花15份、广藿香10份。
进一步的，包括以下重量份的成分：太子参20份、丹参25份、柴胡35份、白茅根45份、紫苏叶30份、桔梗10份、苍术20份、玄参20份、淡豆鼓25份、地龙20份，白头翁30份、杜仲25份、红花20份、广藿香15份。
进一步的，中药可煎服或制备成药丸。
进一步的，煎服的方法具体为：按照重量份比例将各个原料称取后混合，加水煎煮，三碗水煎至一碗得到药汤。
进一步的，制备成药丸的步骤具体步骤如下：
S1、按照配方准备所需原料，并按照相应的重量份比例进行称取；
S2、将步骤S1中称取的中药进行初步粉碎后进行混合后，放入水中进行煎；
S3，取煎煮后的中药浓缩液加乙醇，对其进行充分搅拌和过滤后，再进行浓缩干燥处理，得到含有药效的固态浓缩物；
S4、对固态浓缩物进行粉碎研磨，直至过80～120目筛，用制粒机制备成颗粒状药丸。
进一步的，步骤S2中，初步粉碎后的原料过20～40目筛。
（三）有益效果
与现有技术相比，本发明提供了肺疫清纯中药，具备以下有益效果：
该肺疫清纯中药，其中丹参、柴胡、白茅根、紫苏叶、桔梗、玄参、淡豆豉、白头翁、地龙具有很好的泻火解毒、散寒解表，宣肺止咳的功效，能够快速的对肺疫患者进行治愈，使其症状减轻，同时通过红花、丹参进行活血化瘀，并用杜仲、太子参进行滋补，补脾益肺，益气生津，加速患者的治愈速度，具有一定的保健功能，且无副作用，适用于肺气肿，肺大泡，中期肺癌，肺气虚，支气管炎，肺心病。
具体实施方式
下面将对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例一
肺疫清纯中药，包括以下重量份的成分：太子参15份、丹参10份、柴胡20份、白茅根20份、紫苏叶10份、桔梗10份、苍术15份、玄参20份、淡豆鼓20份、地龙20份，白头翁20份、杜仲20份、红花15份、广藿香5份。
将上述成分制备成药丸的步骤具体步骤如下：
S1、按照配方准备所需原料，并按照上述的重量份比例进行称取；
S2、将步骤S1中称取的中药进行初步粉碎后进行混合后，放入水中进行煎，初步粉碎后的原料过20目筛；
S3，取煎煮后的中药浓缩液加乙醇，对其进行充分搅拌和过滤后，再进行浓缩干燥处理，得到含有药效的固态浓缩物；
S4、对固态浓缩物进行粉碎研磨，直至过120目筛，用制粒机制备成颗粒状药丸。
实施例二
肺疫清纯中药，包括以下重量份的成分：太子参15份、丹参20份、柴胡30份、白茅根40份、紫苏叶20份、桔梗15份、苍术20份、玄参25份、淡豆鼓25份、地龙20份，白头翁30份、杜仲30份、红花15份、广藿香10份。
将上述成分制备成药丸的步骤具体步骤如下：
S1、按照配方准备所需原料，并按照相应的重量份比例进行称取；
S2、将步骤S1中称取的中药进行初步粉碎后进行混合后，放入水中进行煎，初步粉碎后的原料过20目筛；
S3，取煎煮后的中药浓缩液加乙醇，对其进行充分搅拌和过滤后，再进行浓缩干燥处理，得到含有药效的固态浓缩物；
S4、对固态浓缩物进行粉碎研磨，直至过100目筛，用制粒机制备成颗粒状药丸。
实施例三
肺疫清纯中药，包括以下重量份的成分：太子参20份、丹参25份、柴胡35份、白茅根45份、紫苏叶30份、桔梗10份、苍术20份、玄参20份、淡豆鼓25份、地龙20份，白头翁30份、杜仲25份、红花20份、广藿香15份。
将上述成分制备成药丸的步骤具体步骤如下：
S1、按照配方准备所需原料，并按照相应的重量份比例进行称取；
S2、将步骤S1中称取的中药进行初步粉碎后进行混合后，放入水中进行煎，初步粉碎后的原料过40目筛；
S3，取煎煮后的中药浓缩液加乙醇，对其进行充分搅拌和过滤后，再进行浓缩干燥处理，得到含有药效的固态浓缩物；
S4、对固态浓缩物进行粉碎研磨，直至过100目筛，用制粒机制备成颗粒状药丸。
实施例四
肺疫清纯中药，包括以下重量份的成分：太子参15份、丹参10份、柴胡20份、白茅根30份、紫苏叶20份、桔梗15份、苍术20份、玄参20份、淡豆鼓30份、地龙25份，白头翁30份、杜仲30份、红花15份、广藿香5份。
将上述成分制备成药丸的步骤具体步骤如下：
S1、按照配方准备所需原料，并按照相应的重量份比例进行称取；
S2、将步骤S1中称取的中药进行初步粉碎后进行混合后，放入水中进行煎，初步粉碎后的原料过60目筛；
S3，取煎煮后的中药浓缩液加乙醇，对其进行充分搅拌和过滤后，再进行浓缩干燥处理，得到含有药效的固态浓缩物；
S4、对固态浓缩物进行粉碎研磨，直至过120目筛，用制粒机制备成颗粒状药丸。
实施例五
肺疫清纯中药，包括以下重量份的成分：太子参25份、丹参30份、柴胡35份、白茅根45份、紫苏叶30份、桔梗20份、苍术20份、玄参30份、淡豆鼓30份、地龙30份，白头翁30份、杜仲30份、红花20份、广藿香15份。
将上述成分制备成药丸的步骤具体步骤如下：
S1、按照配方准备所需原料，并按照相应的重量份比例进行称取；
S2、将步骤S1中称取的中药进行初步粉碎后进行混合后，放入水中进行煎，初步粉碎后的原料过40目筛；
S3，取煎煮后的中药浓缩液加乙醇，对其进行充分搅拌和过滤后，再进行浓缩干燥处理，得到含有药效的固态浓缩物；
S4、对固态浓缩物进行粉碎研磨，直至过120目筛，用制粒机制备成颗粒状药丸。
将上述五组实施例中制备的药丸，用于同一批患有肺疫的病猪40头，每组实施例的药丸对应8头病猪，持续给药5天，通过观察，得到试验结果，第一组实施例治愈5头，无效0头；第二组实施例治愈7头，无效0头；第三组实施例治愈8头，无效0头；第四组实施例治愈6头，无效0头；第五组实施例治愈6头，无效0头。通过上述结果可以得出，本发明中的肺疫清纯中药，能够有效的治疗肺疫，且其中第三组实施例中的成本比例为最佳比例。
需要说明的是，术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含，从而使得包括一系列要素的过程、方法、物品或者设备不仅包括那些要素，而且还包括没有明确列出的其他要素，或者是还包括为这种过程、方法、物品或者设备所固有的要素。在没有更多限制的情况下，由语句“包括一个……”限定的要素，并不排除在包括所述要素的过程、方法、物品或者设备中还存在另外的相同要素。
尽管已经示出和描述了本发明的实施例，对于本领域的普通技术人员而言，可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型，本发明的范围由所附权利要求及其等同物限定。
Claims (7)
1.肺疫清纯中药，其特征在于,包括以下重量份的成分：太子参15～25份、丹参10～30份、柴胡20～35份、白茅根20～45份、紫苏叶10～30份、桔梗10～20份、苍术15～20份、玄参20～30份、淡豆鼓20～30份、地龙20～30份，白头翁20～30份、杜仲20～30份、红花15～20份、广藿香5～15份。
2.根据权利要求1所述的肺疫清纯中药，其特征在于,包括以下重量份的成分：太子参15份、丹参20份、柴胡30份、白茅根40份、紫苏叶20份、桔梗15份、苍术20份、玄参25份、淡豆鼓25份、地龙20份，白头翁30份、杜仲30份、红花15份、广藿香10份。
3.根据权利要求1所述的肺疫清纯中药，其特征在于,包括以下重量份的成分：太子参20份、丹参25份、柴胡35份、白茅根45份、紫苏叶30份、桔梗10份、苍术20份、玄参20份、淡豆鼓25份、地龙20份，白头翁30份、杜仲25份、红花20份、广藿香15份。
4.根据权利要求1所述的肺疫清纯中药，其特征在于,中药可煎服或制备成药丸。
5.根据权利要求4所述的肺疫清纯中药，其特征在于,煎服的方法具体为：按照重量份比例将各个原料称取后混合，加水煎煮，三碗水煎至一碗得到药汤。
6.根据权利要求1所述的肺疫清纯中药，其特征在于,制备成药丸的步骤具体步骤如下：
S1、按照配方准备所需原料，并按照相应的重量份比例进行称取；
S2、将步骤S1中称取的中药进行初步粉碎后进行混合后，放入水中进行煎；
S3，取煎煮后的中药浓缩液加乙醇，对其进行充分搅拌和过滤后，再进行浓缩干燥处理，得到含有药效的固态浓缩物；
S4、对固态浓缩物进行粉碎研磨，直至过80～120目筛，用制粒机制备成颗粒状药丸。
7.根据权利要求1所述的肺疫清纯中药，其特征在于,步骤S2中，初步粉碎后的原料过20～40目筛。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210004353.3A CN116407598A (zh) | 2022-01-05 | 2022-01-05 | 肺疫清纯中药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210004353.3A CN116407598A (zh) | 2022-01-05 | 2022-01-05 | 肺疫清纯中药 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116407598A true CN116407598A (zh) | 2023-07-11 |
Family
ID=87058635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210004353.3A Withdrawn CN116407598A (zh) | 2022-01-05 | 2022-01-05 | 肺疫清纯中药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116407598A (zh) |
-
2022
- 2022-01-05 CN CN202210004353.3A patent/CN116407598A/zh not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100411649C (zh) | 一种治疗风湿和类风湿性关节炎的中药制剂 | |
| CN1278446A (zh) | 一种治疗脑血管病及风湿类风湿病的中草药组合物 | |
| CN108272874B (zh) | 用于蛋鸡的中药制剂及其制备方法 | |
| CN104013929B (zh) | 一种治疗风湿性关节炎和类风湿性关节炎的风湿祛痛药物及制备方法 | |
| CN116407598A (zh) | 肺疫清纯中药 | |
| CN114377095A (zh) | 一种砂仁-檀香挥发油提取方法、治疗胃炎的胶囊及其制备方法 | |
| CN1111046C (zh) | 一种治疗妇女产后症的中药制剂 | |
| CN103316251A (zh) | 治疗激素依赖性皮炎的中药外用制剂及其制备方法 | |
| CN1712055A (zh) | 一种治疗泌尿系结石的中药制剂(溶石胶囊) | |
| CN109172637B (zh) | 一种治疗风湿的胶囊的制备方法 | |
| CN104688862A (zh) | 气虚血瘀型中风治疗药物和配制方法以及检测方法 | |
| CN1039967A (zh) | 治愈支气管炎口服液的配制方法 | |
| CN112755137B (zh) | 一种治疗轻中度膝骨关节炎的中药组合物及其应用 | |
| CN103386082B (zh) | 一种治疗肝硬化的苗药及制备方法 | |
| RU2815993C1 (ru) | Композиция традиционной китайской медицины для лечения новой коронавирусной пневмонии, способ ее получения, способ ее определения и ее применение | |
| CN115282232B (zh) | 治疗肾病的中药组合物、提取物、制备方法及应用和制剂 | |
| CN101194940A (zh) | 治疗牙痛的消炎药物及其制作方法 | |
| CN107595957B (zh) | 一种藏药玛诺系汤化石组合物及其制备方法 | |
| CN1310669C (zh) | 一种治疗慢性肝炎的药物组合物及其制备方法 | |
| CN102258731A (zh) | 一种治疗尿频的中药组合物 | |
| CN1709478A (zh) | 治疗妇科疾病中药制剂的制备方法 | |
| CN105816548A (zh) | 一种治疗风热感冒的中药组合物及其制备方法 | |
| CN104800339A (zh) | 一种用于治疗骨折的中药组合物 | |
| CN116135223A (zh) | 一种功能药剂配方及其制备工艺方法 | |
| CN113694164A (zh) | 一种风湿树及其理疗方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20230711 |